269 related articles for article (PubMed ID: 12416994)
1. Ellman's-reagent-mediated regeneration of trypanothione in situ: substrate-economical microplate and time-dependent inhibition assays for trypanothione reductase.
Hamilton CJ; Saravanamuthu A; Eggleston IM; Fairlamb AH
Biochem J; 2003 Feb; 369(Pt 3):529-37. PubMed ID: 12416994
[TBL] [Abstract][Full Text] [Related]
2. Mycothiol disulfide reductase: a continuous assay for slow time-dependent inhibitors.
Hamilton CJ; Finlay RM; Stewart MJ; Bonner A
Anal Biochem; 2009 May; 388(1):91-6. PubMed ID: 19233116
[TBL] [Abstract][Full Text] [Related]
3. Glutathione reductase turned into trypanothione reductase: structural analysis of an engineered change in substrate specificity.
Stoll VS; Simpson SJ; Krauth-Siegel RL; Walsh CT; Pai EF
Biochemistry; 1997 May; 36(21):6437-47. PubMed ID: 9174360
[TBL] [Abstract][Full Text] [Related]
4. The parasite-specific trypanothione metabolism of trypanosoma and leishmania.
Krauth-Siegel RL; Meiering SK; Schmidt H
Biol Chem; 2003 Apr; 384(4):539-49. PubMed ID: 12751784
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of substrate analogue inhibitors of trypanothione reductase.
Duyzend MH; Clark CT; Simmons SL; Johnson WB; Larson AM; Leconte AM; Wills AW; Ginder-Vogel M; Wilhelm AK; Czechowicz JA; Alberg DG
J Enzyme Inhib Med Chem; 2012 Dec; 27(6):784-94. PubMed ID: 22085139
[TBL] [Abstract][Full Text] [Related]
6. Drug target validation of the trypanothione pathway enzymes through metabolic modelling.
Olin-Sandoval V; González-Chávez Z; Berzunza-Cruz M; Martínez I; Jasso-Chávez R; Becker I; Espinoza B; Moreno-Sánchez R; Saavedra E
FEBS J; 2012 May; 279(10):1811-33. PubMed ID: 22394478
[TBL] [Abstract][Full Text] [Related]
7. The synthesis and inhibitory activity of dethiotrypanothione and analogues against trypanothione reductase.
Czechowicz JA; Wilhelm AK; Spalding MD; Larson AM; Engel LK; Alberg DG
J Org Chem; 2007 May; 72(10):3689-93. PubMed ID: 17439174
[TBL] [Abstract][Full Text] [Related]
8. Crystal structure of Trypanosoma cruzi trypanothione reductase in complex with trypanothione, and the structure-based discovery of new natural product inhibitors.
Bond CS; Zhang Y; Berriman M; Cunningham ML; Fairlamb AH; Hunter WN
Structure; 1999 Jan; 7(1):81-9. PubMed ID: 10368274
[TBL] [Abstract][Full Text] [Related]
9. Time-dependent inhibitors of trypanothione reductase: analogues of the spermidine alkaloid lunarine and related natural products.
Hamilton CJ; Saravanamuthu A; Poupat C; Fairlamb AH; Eggleston IM
Bioorg Med Chem; 2006 Apr; 14(7):2266-78. PubMed ID: 16303308
[TBL] [Abstract][Full Text] [Related]
10. Interaction of nitric oxide with 2-thio-5-nitrobenzoic acid: implications for the determination of free sulfhydryl groups by Ellman's reagent.
Gergel' D; Cederbaum AI
Arch Biochem Biophys; 1997 Nov; 347(2):282-8. PubMed ID: 9367537
[TBL] [Abstract][Full Text] [Related]
11. Trypanothione reductase from the human parasite Entamoeba histolytica: a new drug target.
Tamayo EM; Iturbe A; Hernández E; Hurtado G; de Lourdes Gutiérrez-X M; Rosales JL; Woolery M; Ondarza RN
Biotechnol Appl Biochem; 2005 Apr; 41(Pt 2):105-15. PubMed ID: 15157186
[TBL] [Abstract][Full Text] [Related]
12. Trypanothione biosynthesis in Leishmania major.
Oza SL; Shaw MP; Wyllie S; Fairlamb AH
Mol Biochem Parasitol; 2005 Jan; 139(1):107-16. PubMed ID: 15610825
[TBL] [Abstract][Full Text] [Related]
13. Expression, purification, and characterization of Leishmania donovani trypanothione reductase in Escherichia coli.
Mittal MK; Misra S; Owais M; Goyal N
Protein Expr Purif; 2005 Apr; 40(2):279-86. PubMed ID: 15766869
[TBL] [Abstract][Full Text] [Related]
14. Synthesis of substrate analogues for trypanothione reductase.
el-Waer AF; Benson T; Douglas KT
Int J Pept Protein Res; 1993 Feb; 41(2):141-6. PubMed ID: 8458687
[TBL] [Abstract][Full Text] [Related]
15. Specific peptide inhibitors of trypanothione reductase with backbone structures unrelated to that of substrate: potential rational drug design lead frameworks.
McKie JH; Garforth J; Jaouhari R; Chan C; Yin H; Besheya T; Fairlamb AH; Douglas KT
Amino Acids; 2001; 20(2):145-53. PubMed ID: 11332449
[TBL] [Abstract][Full Text] [Related]
16. Rationally designed selective inhibitors of trypanothione reductase. Phenothiazines and related tricyclics as lead structures.
Benson TJ; McKie JH; Garforth J; Borges A; Fairlamb AH; Douglas KT
Biochem J; 1992 Aug; 286 ( Pt 1)(Pt 1):9-11. PubMed ID: 1355650
[TBL] [Abstract][Full Text] [Related]
17. Molecular docking of a series of peptidomimetics in the trypanothione binding site of T. cruzi trypanothione reductase.
da Rocha Pita SS; Cirino JJ; de Alencastro RB; Castro HC; Rodrigues CR; Albuquerque MG
J Mol Graph Model; 2009 Nov; 28(4):330-5. PubMed ID: 19766515
[TBL] [Abstract][Full Text] [Related]
18. Design, synthesis and biological evaluation of new potent 5-nitrofuryl derivatives as anti-Trypanosoma cruzi agents. Studies of trypanothione binding site of trypanothione reductase as target for rational design.
Aguirre G; Cabrera E; Cerecetto H; Di Maio R; González M; Seoane G; Duffaut A; Denicola A; Gil MJ; Martínez-Merino V
Eur J Med Chem; 2004 May; 39(5):421-31. PubMed ID: 15110968
[TBL] [Abstract][Full Text] [Related]
19. Trypanothione efficiently intercepts nitric oxide as a harmless iron complex in trypanosomatid parasites.
Bocedi A; Dawood KF; Fabrini R; Federici G; Gradoni L; Pedersen JZ; Ricci G
FASEB J; 2010 Apr; 24(4):1035-42. PubMed ID: 19952282
[TBL] [Abstract][Full Text] [Related]
20. Structural insights into the enzymes of the trypanothione pathway: targets for antileishmaniasis drugs.
Colotti G; Baiocco P; Fiorillo A; Boffi A; Poser E; Chiaro FD; Ilari A
Future Med Chem; 2013 Oct; 5(15):1861-75. PubMed ID: 24144416
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
